Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mammogram Recommendations Show Perils Of Communicating CER Results

Executive Summary

The controversy surrounding the recent recommendations on mammogram screenings by the U.S. Preventive Services Task Force has the potential to be played out again amid the continued push for more comparative effectiveness research

You may also be interested in...



Patient Focus Could Shield PCORI From Controversy When Findings Contradict Accepted Standards

Having patients involved in all facets of the research process could help protect the Patient-Centered Outcomes Research Institute from controversy should research findings contradict generally accepted standards of care, speakers at a comparative effectiveness summit said.

Methods Research Dominates PCORI Pilot Projects

The Patient-Centered Outcomes Research Institute announced the awardees of pilot project research funds, with many winners emphasizing research that advances the methodology of conducting patient-centered outcomes research.

Cost Effectiveness Analysis In CER: Perhaps Not So Controversial After All?

Recent examination of cost effectiveness analyses conducted as part of comparative effectiveness research reveals that CEA and CER were in agreement about 70% of the time.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051766

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel